"Space-Based Cancer Research Unveils Potential 'Kill Switch' for Tumors"

California researchers have sent miniature tumor organoids to space to study cancer growth and the effects of treatments in microgravity, leading to the discovery of a potential "kill switch" for cancer. The team, led by Dr. Catriona H.M. Jamieson, observed rapid cancer progression and identified a cloning gene, ADAR1, as a key factor. They tested anti-cancer medications on space tumors and found promising results with an experimental drug called rebecsinib, which inhibits cancer growth significantly. The team aims to launch the drug into clinical trials on Earth by the end of the year, with hope and support from NASA and European astronauts.